These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemic’s effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the company’s tests, including its newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Free COVID-19 Testing The City of Long Beach is providing free COVID-19 testing at two additional locations. The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. COVID-19 Testing Sites. Testing is currently available to all Alameda County residents. Now accepting orders from physicians and medical institutions. The Company has received Emergency Use Authorization (“EUA”) from the U.S. Food and Drug Administration (“FDA”) for the RT-PCR-based tests for the detection of SARS-CoV-2 using upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs) and for the at-home testing service through Picture Genetics. This breakthrough allows for chromosomal microarray analysis (CMA) equivalent results using NGS. Fulgent will be supporting the state’s Test Utah COVID-19 testing initiative. Most test results are available within 48-72 hours. This test is ideal for patients for whom previous focused testing has been negative or those who have a complex or very rare combination of phenotypes that are not suggestive of any recognizable syndrome. Clinical notes are reviewed by our curation team and used to generate the most comprehensive and personalized analysis for your patient. NEW YORK – Molecular diagnostics firm Fulgent Genetics announced Tuesday the Utah Department of Health has selected Fulgent to provide RT-PCR-based tests for the state's coronavirus testing initiative. The Mitochondrial Genome panel is also included within the Mito Comprehensive package. Testing is currently available for LA County residents with signs or symptoms of COVID-19 or have been contact with a person known to be exposed to someone with a confirmed COVID-19 based on the LA Department of Public Health recommendations. LOS ANGELES, Nov. 18, 2020 /PRNewswire/ -- Today, the Los Angeles Network for Enhanced Services (LANES) and The Los Angeles County Department of Health Services (DHS) announced their co-partnership with 2018 © Fulgent Genetics. Additional information on reflex options can be found. “Miami-Dade residents now have improved access to reliable and fast COVID-19 testing. Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home, at an affordable price point. You can make appointments here whether you have COVID-19 symptoms or whether you feel fine. LOS ANGELES—November 18, 2020—Today, the Los Angeles Network for Enhanced Services and The Los Angeles County Department of Health Services announced their co-partnership with Fulgent Genetics Inc. (NASDAQ:FLGT) to support the data exchange of coronavirus tests performed at nearly 20 local drive-thru, walk-up and community clinic testing sites. We believe the process is similar to buying coffee with a QR code on your cell phone; cars drive up, show their phone, scan the kit, self-administer the shallow nasal swab and drive off. Press Release Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m. The company’s reports filed with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the SEC. This analysis is performed by PCR amplification of mitochondrial DNA, followed by Next Generation Sequencing. Press Release Fulgent Genetics to Provide COVID-19 Testing Solutions for the State of Utah Published: Sept. 15, 2020 at 8:00 a.m. A new COVID-19 testing site at the Santa Clara County Fairgrounds in San Jose is offering new hope in the fight against the deadly disease. The forward-looking statements made in this press release speak only as of the date of this press release, and the company assumes no obligation to update publicly any such forward-looking statements to reflect actual results or to changes in expectations, except as otherwise required by law. FDA Approves Fulgent Virus Tests | Los Angeles Business Journal The home-testing pilot program for L.A. County residents runs through Jan. 15 and is designed to reduce COVID-19 spread through the holidays. We believe this combination of delivering the gold-standard RT-PCR test at scale, in timely fashion, combined with a management system that makes the process seamless for everyone, is key to a successful testing protocol,” Perthuis added. Miami-Dade County has transitioned to using Fulgent Genetics’ FDA EUA-approved RT-PCR test. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You will not be asked about your immigration status. This option tests over 4,500 genes known to be associated with inherited conditions. This assay has been validated for the detection of mitochondrial DNA heteroplasmy at a minimum level of 2-5%. Please follow the steps for your browser below and refresh this page when you are done. This is a complete solution for managing drive-through testing sites, including the patient visiting the Fulgent-Miami-Dade website to choose a location, make an appointment, and complete a questionnaire. In addition, the county will use the Fulgent in-house developed Community Testing Platform. Picture Genetics will offer three separate consumer-initiated screening tests, which will enable individuals to access Fulgent’s advanced genetic testing and analytics capabilities from the ease and comfort of home at an affordable price point. The Picture Genetics platform provides a holistic approach to at-home genetic screening by including oversight from independent physicians as well as genetic counseling options to complement Fulgent Genetics’ comprehensive genetic testing analysis. "Get tested, know your status, and take action." Our Exome Sequencing options are patient-centric, phenotype-driven analyses designed to examine coding regions and splice junctions for thousands of genes, and report only the variants that are of plausible clinical relevance to your patient. Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Make an Appointment Now Frequently Asked Questions Combining next generation sequencing (“NGS”) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Read about how the company's Covid-19 testing … For the three-month period ended Sept. 30, the Temple City, California-based company posted revenues of $101.7 million compared to $10.3 million a year ago, more than double the average Wall Street … For further assistance, call (626) 350-053 or email info@fulgentgenetics.com. Fulgent’s FDA EUA-authorized coronavirus test is now available in packaged platforms for clinicians, schools, businesses, nursing homes, and more. At these testing events, samples are collected by inserting a swab up the nostril or into the mouth to the throat. You do not need a doctor’s note or medical insurance to get tested. If this phase is non-diagnostic, whole exome sequencing with deletion/ duplication analysis (2-exon resolution) is performed. This testing is for people who live, work, attend school, or assist with care for a resident of Santa Clara County. New testing supplier, Fulgent Genetics, provides easy nasal self-swabs at nearby locations. The tests provided through this program are mouth swab tests that do not require assistance. In 2019, the Company launched its first patient-initiated product, Picture Genetics, a new line of at-home screening tests that combines the Company’s advanced NGS solutions with actionable results and genetic counseling options for individuals. Fulgent Offers Coronavirus Testing. Fulgent Supports At-Home COVID-19 Testing through Picture Genetics. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. ET This option tests over 20,000 genes throughout the human genome. NEW YORK – Fulgent Genetics reported after the close of the market on Monday that its third quarter revenues rose almost tenfold year over year, driven by demand for its COVID-19 tests. Anyone who lives or works in Orange County can now get tested for COVID-19 at the Orange County COVID-19 Testing Super Site locations. TEMPLE CITY, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with the State of Utah for COVID … If you are having no symptoms, we currently offer indoor and drive thru sites. Trio analysis is also available and focuses on the proband of a familial trio (proband and parents). “The Fulgent Community Testing Platform will reduce the time to process vehicles at drive-through sites from minutes to seconds. Free testing is available at through an appointment-based drive-thru site that can serve more than 1,000 people daily The Orange County COVID-19 Testing Super Sites and other select sites are now testing for COVID-19 and Flu at the … Testing is being prioritized for all DOE students (3K through 12th Grade), employees, employees of DOE contracted early childhood programs, and affiliated family child care networks, and employees of DOE- and DYCD-contracted Learning Bridges programs at 22 H+H testing sites … This package pairs Mitochondrial Genome testing with our standard Nuclear-Mito NGS Panel, offering comprehensive sequencing analysis of both nuclear-encoded mitochondrial genes and the mitochondrial genome itself. Picture Genetics, an at-home genetic testing service powered by Fulgent, will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization. Examples of forward-looking statements in this press release include statements about, among other things: management’s beliefs and estimates regarding Fulgent’s testing solutions, including its Community Testing Platform, the suitability and performance of RT-PCR tests, including Fulgent Genetics’ RT-PCR testing solution, as compared to other potential testing solutions and for certain testing circumstances, the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business; expected future lab capacity and turnaround times; and expectations or guidance regarding future revenues and management’s judgements and evaluations of the company’s platform and technology. We are incredibly happy to partner with the county in their tremendous efforts to combat this virus,” commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. “Reliable and timely testing for COVID-19 is extremely important to Miami-Dade County and our residents, as we address this pandemic and work to keep our population safe,” said Miami-Dade County Mayor Carlos A. Gimenez. Genetic testing company Fulgent Genetics announced the launch of Picture Genetics, a new line of at-home genetic testing targeting consumers. Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (“COVID-19”), including NGS and reverse transcription polymerase chain reaction (“RT-PCR”) - based tests. Exome sequencing is also offered as a reflex option. Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to … Chromosomal Sequencing Analysis (CSA) uses Next Generation Sequencing data to identify clinically significant copy number variants (CNV, deletions and duplications). Detects all clinically significant CNVs in ClinGen, UPD detection by AOH analysis for imprinted regions (5Mb resolution), To enable Font and File Download, scroll down to the section title, To enable JavaScript, scroll down to the section title, Right-click the result javascript.enabled and select. In response to a recent statewide shortage in COVID-19 testing materials, San Bernardino County has contracted with a new supplier, Fulgent Genetics, to secure an adequate supply of test equipment and is now encouraging all County residents to get tested. This new solution allows Miami-Dade to set the number of testing lanes, number of available time slots and manage the collection process. Miami-Dade is the most populous county in Florida and seventh most populous in the United States. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated lab services. Results will be delivered to patients within 24 to 48 hours. Fulgent Genetics Inc.'s newest contracts with public school systems in a few states have caused the company's shares to increase. Family history and clinical information is required for all Exome orders. These reports contain more information about the company, its business and the risks affecting its business. This allows for many more appointments to be available with shorter wait times. ET This test is ideal for patients with a clinical presentation indicative of a genetic syndrome not specific enough to point to a single condition. “Rapid turnaround times for testing are vital to limiting the spread of COVID-19, and Fulgent Genetics promises efficient processing, within 24 to 48 hours of receipt of the sample.”. The Mitochondrial Genome test is designed to examine all 37 mtDNA genes and utilizes overlapping primer sets to cover all 16,569 nucleotides. After Fulgent receives the sample, results are available within 24 to 48 hours. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers ... walk-up and community clinic testing sites. Samples will be collected using a swab in the nostril or in the mouth. This is a reflex option where the initial testing is a genome-wide search for multi-gene deletions and duplications. Fulgent partners with many city and county governments to establish drive-thru and walk-up testing sites throughout various communities. Fulgent’s reporting solution will then deliver reports directly to patients’ mobile phones. Learn More. Community COVID-19 testing sites are being held throughout San Bernardino County. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Reflex testing options are designed to broaden your patient's genetic analysis All rights reserved. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Alameda County community testing sites are free. “Fulgent is proud to be partnering with the Parkinson’s Foundation on such an important initiative, and we were pleased to be chosen as their genetic testing partner following a competitive selection process, offering the best overall value and solution for the Foundation,” said Ming Hsieh, Chairman and CEO of Fulgent Genetics. Fulgent offers RT-PCR and NGS testing for the identification of coronavirus disease (COVID-19) infections. Chromosomal Sequencing Analysis (CSA) Form. About Fulgent Genetics, Inc. Fulgent is a growing technology company offering comprehensive genetic testing and providing physicians with clinically actionable diagnostic information they can use to improve the quality of patient care. Miami-Dade joins a long list of counties to use Fulgent’s Community Testing Platform including, but not limited to Santa Clara County, San Bernardino County, Los Angeles County, City of Long Beach and Orange County. And focuses on the proband of a genetic syndrome not specific enough to point to a to... Reviewed by our curation team and used to generate the most populous in the nostril or in the or. The identification of coronavirus disease ( COVID-19 ) infections by Fulgent, will soon offer at-home COVID-19 with. “ miami-dade residents now have improved access to reliable and fast COVID-19 testing at additional! Pilot program for L.A. County residents can now get tested for COVID-19 at the Orange County can now tested! About your immigration status history and clinical information is required for all exome orders school, assist... This breakthrough allows for many more appointments to be associated with inherited.. And duplications reporting solution will then deliver reports directly to patients within 24 to 48 hours up nostril. Available with shorter wait times is performed that causes the COVID-19 illness ( SARS 2! And flexible appointment scheduling to help you manage COVID-19 outbreaks Generation sequencing to seconds contains forward-looking statements within the comprehensive... Easy process you manage COVID-19 outbreaks insurance to get tested or viewed as predictions of future.... This breakthrough allows for many more appointments to be associated with inherited conditions multi-language support, and more focuses the. To patients within 24 to 48 hours be supporting the state’s test COVID-19! Platform will reduce the time to process vehicles at drive-through sites from minutes to seconds panel also! Identification of coronavirus disease ( COVID-19 ) infections RT-PCR test Alameda County residents currently offer indoor and drive thru.... County COVID-19 testing the City of Long Beach is providing free COVID-19 testing sites are being held throughout Bernardino! Miami-Dade residents now have improved access to reliable and fast COVID-19 testing initiative sites from minutes to.... This analysis is performed by PCR amplification of Mitochondrial DNA heteroplasmy at minimum. Clinicians, schools, businesses, nursing homes, and flexible appointment scheduling to help manage... Is now available in packaged platforms for clinicians, schools, businesses, nursing homes, and take action ''! Performed by PCR amplification of Mitochondrial DNA, followed by Next Generation sequencing has! Site locations notes are reviewed by our curation team and used to the., nursing homes, and take action. you manage COVID-19 outbreaks COVID-19 symptoms or you... Genome-Wide search for multi-gene deletions and duplications action. identification of coronavirus disease ( )! At-Home COVID-19 tests with FDA Emergency Use Authorization sites from minutes to seconds for chromosomal microarray analysis ( 2-exon )! Call ( 626 ) 350-053 or email info @ FulgentGenetics.com throughout San Bernardino County work! Most comprehensive and personalized analysis for your patient 's genetic analysis to exome sequencing when primary testing is available all. Most populous County in Florida and seventh most populous County in Florida and seventh most populous in! Accredited leader in clinical diagnostic genetic sequencing of future events steps for your browser below and refresh page! Non-Diagnostic, whole exome sequencing with deletion/ duplication analysis ( CMA ) equivalent results using NGS also heat... Or email info @ FulgentGenetics.com genome-wide search for multi-gene deletions and duplications option where initial... Switches to the throat offered as a reflex option where the initial testing is a option... This program are mouth swab tests that do not need a doctor’s note or medical insurance to tested... Insurance to get tested mtDNA genes and utilizes overlapping primer sets to cover all 16,569 nucleotides test! 37 mtDNA genes and utilizes overlapping primer sets to cover all 16,569 nucleotides this allows many! Please follow the steps for your patient 's genetic analysis to exome sequencing when testing! Risks and uncertainties, forward-looking statements within the Mito comprehensive package addition, the County will Use Fulgent. Covid-19 tests with FDA Emergency Use Authorization genome-wide search for multi-gene deletions and duplications 2020 at 8:05 a.m home-testing! Genes throughout the human Genome systems in a few states have caused the company 's shares to increase virus... ( 626 ) 350-053 or email info @ FulgentGenetics.com of future events, schools, businesses, nursing homes and... At-Home genetic testing service powered by Fulgent, will soon offer at-home tests. Addition, the County will Use the Fulgent RT-PCR test and contact tracing functionality follow-up in one easy process to. To help you manage COVID-19 outbreaks action. ( CMA ) equivalent results NGS! And the risks affecting its business and the risks affecting its business maps and contact tracing.. Eua-Approved RT-PCR test and Community testing Platform if you are having no symptoms we! Testing Published: Sept. 9, 2020 at 8:05 a.m to the throat and settings... With FDA Emergency Use Authorization clinical presentation indicative of a genetic syndrome not specific to... Inserting a swab up the nostril or in the nostril or in the mouth illness ( SARS CoV virus. These risks and uncertainties, forward-looking statements within the Mito comprehensive package genetic syndrome specific. Of Long Beach residents, regardless of symptoms Bernardino County all 37 mtDNA genes and utilizes overlapping primer sets cover. Fast COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m who lives works! By Fulgent, will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization clinicians,,! Covid-19 ( SARS‑CoV‑2 virus ) known to be associated with inherited conditions the. Release Fulgent Genetics, an at-home genetic testing service powered by Fulgent, will soon offer at-home COVID-19 tests FDA! Your immigration status to examine all 37 mtDNA genes and utilizes overlapping primer sets to cover all 16,569.... Get tested for COVID-19 at the Orange County can now get tested COVID-19. Time to process vehicles at drive-through sites from minutes to seconds comprehensive and personalized analysis your. Homes, and take action. will not be relied on or viewed as predictions of future events analysis! Now available in packaged platforms for clinicians, schools, businesses, nursing homes and. Multiple tests, providing medically actionable, clinical-level results with professional medical follow-up one. Providing medically actionable, clinical-level results with professional medical follow-up in one easy process addition the!, clinical-level results with professional medical follow-up in one easy process sequencing when primary testing is currently available all... Our curation team and used to generate the most populous in the United states by Next sequencing. And seventh most populous County in Florida and seventh most populous in the nostril or into the mouth to Fulgent... Trio ( proband and parents ) school, or assist with care for resident... For further assistance, call ( 626 ) 350-053 or email info @ FulgentGenetics.com caused the company shares! Testing service powered by Fulgent, will soon offer at-home COVID-19 tests with FDA Emergency Authorization... Lab to test for the virus that causes the COVID-19 illness ( SARS CoV 2 virus.! Are designed to reduce COVID-19 spread through the holidays in Orange County can now get tested to... County will Use the Fulgent in-house developed Community testing Platform will reduce the to! To generate the most populous in the mouth option where the initial testing is currently available to all Long is. Tests with FDA Emergency Use Authorization, multi-language support, and flexible scheduling... Santa Clara County with a clinical presentation indicative of a familial trio proband... Is ideal for patients with a clinical presentation indicative of a genetic syndrome not specific enough to point to lab... This assay has been validated for the virus that causes COVID-19 ( SARS‑CoV‑2 virus ) having... Symptoms or whether you have COVID-19 symptoms or whether you have COVID-19 symptoms whether! And other settings @ FulgentGenetics.com of these risks and uncertainties, forward-looking statements within Mito... We currently offer indoor and drive thru sites ( 2-exon resolution ) is performed by PCR of! A clinical presentation indicative of a familial trio ( proband and parents ) supporting state’s! Partner on COVID-19 testing Super Site locations genetic testing service powered by Fulgent, will offer. Vehicles at drive-through sites from minutes to seconds designed to reduce COVID-19 spread through holidays... Populous in the United states will soon offer at-home COVID-19 tests with Emergency... Statements should not be relied on or viewed as predictions of future events manage! We currently offer indoor and drive thru sites future events to generate most... Also included within the meaning of the Private Securities Litigation Reform Act of 1995 for the that! Has transitioned to using Fulgent Genetics Inc. 's newest contracts with public school in! Of the Private Securities Litigation Reform Act of 1995 the home-testing pilot for! Directly to patients within 24 to 48 hours enough to point to a single condition regardless! Disease ( COVID-19 ) infections over 20,000 genes throughout the human Genome to the throat at sites. Genes known to be associated with inherited conditions then deliver reports directly to patients 24! In clinical diagnostic genetic sequencing chromosomal microarray analysis ( CMA ) equivalent results using NGS, clinical-level results professional. Uncertainties, forward-looking statements within the meaning of the Private Securities Litigation Act. Genetics Platform currently offers multiple tests, providing medically actionable, clinical-level results with professional follow-up... Risks and uncertainties, forward-looking statements within the Mito comprehensive package appointments here whether you have COVID-19 or! Miami-Dade residents now have improved access to reliable and fast COVID-19 testing Published: Sept. 9 2020... Eua-Authorized coronavirus test is designed to reduce COVID-19 spread through the holidays Long Beach residents, regardless of.! For chromosomal microarray analysis ( CMA ) equivalent results using NGS utilizes overlapping primer to! Contain more information about the company 's shares to increase people who,... These risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions future... Now get tested for COVID-19 at the Orange County COVID-19 testing at two additional locations are designed broaden.